FDA Inspection
ANI Pharmaceuticals, Inc.ANI Pharmaceuticals, Inc. – FDA Inspection, Dec 6, 2024
Record Details
This FDA Inspection record concerns ANI Pharmaceuticals, Inc., with an inspection on December 6, 2024, issued by the Minneapolis District Office, covering human drugs.
View Company Profile
ID · f02933d2-37d4-4b62-9d46-58d36606a572
Inspection Facts
- Inspection number
- 1250465
- FDA center
- Human Drugs
- Outcome
- Form 483 issued
Other FDA inspections of ANI Pharmaceuticals, Inc.
10| Date | Classification | Office | Project area |
|---|---|---|---|
| November 18, 2022 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| April 12, 2019 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| May 18, 2017 | Not classified | Minneapolis District Office | |
| July 28, 2016 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| September 27, 2013 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for ANI Pharmaceuticals, Inc.
- FDA Inspection 1191619 - 2022-11-18
- FDA Inspection 1089435 - 2019-04-12
- FDA Inspection 1016454 - 2017-05-18
- FDA Inspection 983493 - 2016-07-28
- FDA Inspection 852937 - 2013-09-27
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.